SEARCH

SEARCH BY CITATION

References

  • 1
    Vendrell J,Broch M,Vilarrasa N,Molina A,Gomez JM,Gutierrez C,Simon I,Soler J,Richart C. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes Res 2004; 12: 96271.
  • 2
    Housa D,Housova J,Vernerova Z,Haluzik M. Adipocytokines and cancer. Physiol Res 2006; 55: 23344.
  • 3
    Balkwill F,Coussens LM. Cancer: an inflammatory link. Nature 2004; 431: 4056.
  • 4
    Clevers H. At the crossroads of inflammation and cancer. Cell 2004; 118: 6714.
  • 5
    Haramis AP,Hurlstone A,van der Velden Y,Begthel H,van den Born M,Offerhaus GJ,Clevers HC. Adenomatous polyposis coli-deficient zebrafish are susceptible to digestive tract neoplasia. EMBO Rep 2006; 7: 4449.
  • 6
    Alavi K,Schwartz MZ,Prasad R,O'Connor D,Funanage V. Leptin: a new growth factor for the small intestine. J Pediatr Surg 2002; 37: 32730.
  • 7
    Chen DC,Chung YF,Yeh YT,Chaung HC,Kuo FC,Fu OY,Chen HY,Hou MF,Yuan SS. Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett 2006; 237: 10914.
  • 8
    Saglam K,Aydur E,Yilmaz M,Goktas S. Leptin influences cellular differentiation and progression in prostate cancer. J Urol 2003; 169: 130811.
  • 9
    Goktas S,Yilmaz MI,Caglar K,Sonmez A,Kilic S,Bedir S. Prostate cancer and adiponectin. Urology 2005; 65: 116872.
  • 10
    Attoub S,Noe V,Pirola L,Bruyneel E,Chastre E,Mareel M,Wymann MP,Gespach C. Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, rho-, and rac-dependent signaling pathways. FASEB J 2000; 14: 232938.
  • 11
    Hardwick JC,Van Den Brink GR,Offerhaus GJ,Van Deventer SJ,Peppelenbosch MP. Leptin is a growth factor for colonic epithelial cells. Gastroenterology 2001; 121: 7990.
  • 12
    Aparicio T,Kotelevets L,Tsocas A,Laigneau JP,Sobhani I,Chastre E,Lehy T. Leptin stimulates the proliferation of human colon cancer cells in vitro but does not promote the growth of colon cancer xenografts in nude mice or intestinal tumorigenesis in Apc(Min/+) mice. Gut 2005; 54: 113645.
  • 13
    Okumura M,Yamamoto M,Sakuma H,Kojima T,Maruyama T,Jamali M,Cooper DR,Yasuda K. Leptin and high glucose stimulate cell proliferation in MCF-7 human breast cancer cells: reciprocal involvement of PKC-α and PPAR expression. Biochim Biophys Acta 2002; 1592: 10716.
  • 14
    Somasundar P,Yu AK,Vona-Davis L,McFadden DW. Differential effects of leptin on cancer in vitro. J Surg Res 2003; 113: 505.
  • 15
    Frankenberry KA,Somasundar P,McFadden DW,Vona-Davis LC. Leptin induces cell migration and the expression of growth factors in human prostate cancer cells. Am J Surg 2004; 188: 5605.
  • 16
    Choi JH,Park SH,Leung PC,Choi KC. Expression of leptin receptors and potential effects of leptin on the cell growth and activation of mitogen-activated protein kinases in ovarian cancer cells. J Clin Endocrinol Metab 2005; 90: 20710.
  • 17
    Fenton JI,Hord NG,Lavigne JA,Perkins SN,Hursting SD. Leptin, insulin-like growth factor-1, and insulin-like growth factor-2 are mitogens in ApcMin/+ but not Apc+/+ colonic epithelial cell lines. Cancer Epidemiol Biomarkers Prev 2005; 14: 164652.
  • 18
    Fenton JI,Hursting SD,Perkins SN,Hord NG. Interleukin-6 production induced by leptin treatment promotes cell proliferation in an Apc(Min/+) colon epithelial cell line. Carcinogenesis 2006; 27: 150715.
  • 19
    Yamauchi T,Kamon J,Minokoshi Y,Ito Y,Waki H,Uchida S,Yamashita S,Noda M,Kita S,Ueki K,Eto K,Akanuma Y, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002; 8: 128895.
  • 20
    Bottner A,Kratzsch J,Muller G,Kapellen TM,Bluher S,Keller E,Bluher M,Kiess W. Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J Clin Endocrinol Metab 2004; 89: 405361.
  • 21
    Suzuki S,Wilson-Kubalek EM,Wert D,Tsao TS,Lee DH. The oligomeric structure of high molecular weight adiponectin. FEBS Lett 2007; 581: 80914.
  • 22
    Pajvani UB,Hawkins M,Combs TP,Rajala MW,Doebber T,Berger JP,Wagner JA,Wu M,Knopps A,Xiang AH,Utzschneider KM,Kahn SE, et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem 2004; 279: 1215262.
  • 23
    Koerner A,Kratzsch J,Kiess W. Adipocytokines: leptin-the classical, resistin-the controversical, adiponectin-the promising, and more to come. Best Pract Res Clin Endocrinol Metab 2005; 19: 52546.
  • 24
    Kadowaki T,Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 2005; 26: 43951.
  • 25
    Yamauchi T,Nio Y,Maki T,Kobayashi M,Takazawa T,Iwabu M,Okada-Iwabu M,Kawamoto S,Kubota N,Kubota T,Ito Y,Kamon J, et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med 2007; 13: 3329.
  • 26
    Wei EK,Giovannucci E,Fuchs CS,Willett WC,Mantzoros CS. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst 2005; 97: 168894.
  • 27
    Housa D,Vernerova Z,Heracek J,Prochazka B,Cechak P,Kuncova J,Haluzik M. Adiponectin as a potential marker of prostate cancer progression: studies in organ-confined and locally advanced prostate cancer. Physiol Res (in press).
  • 28
    Kang JH,Lee YY,Yu BY,Yang BS,Cho KH,Yoon do K,Roh YK. Adiponectin induces growth arrest and apoptosis of MDA-MB-231 breast cancer cell. Arch Pharm Res 2005; 28: 12639.
  • 29
    Dieudonne MN,Bussiere M,Dos Santos E,Leneveu MC,Giudicelli Y,Pecquery R. Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. Biochem Biophys Res Commun 2006; 345: 2719.
  • 30
    Fenton JI,Hord NG. Stage matters: choosing relevant model systems to address hypotheses in diet and cancer chemoprevention research. Carcinogenesis 2006; 27: 893902.
  • 31
    Whitehead RH,VanEeden PE,Noble MD,Ataliotis P,Jat PS. Establishment of conditionally immortalized epithelial cell lines from both colon and small intestine of adult H-2Kb-tsA58 transgenic mice. Proc Natl Acad Sci USA 1993; 90: 58791.
  • 32
    Whitehead RH,Joseph JL. Derivation of conditionally immortalized cell lines containing the Min mutation from the normal colonic mucosa and other tissues of an “Immortomouse”/Min hybrid. Epithelial Cell Biol 1994; 3: 11925.
  • 33
    D'Abaco GM,Whitehead RH,Burgess AW. Synergy between Apc min and an activated ras mutation is sufficient to induce colon carcinomas. Mol Cell Biol 1996; 16: 88491.
  • 34
    Fenton JI,Wolff MS,Orth MW,Hord NG. Membrane-type matrix metalloproteinases mediate curcumin-induced cell migration in non-tumorigenic colon epithelial cells differing in Apc genotype. Carcinogenesis 2002; 23: 106570.
  • 35
    Fenton JI,Hursting SD,Perkins SN,Hord NG. Interleukin-6 production induced by leptin treatment promotes cell proliferation in an Apc(Min/+) colon epithelial cell line. Carcinogenesis 2006; 27: 150715.
  • 36
    Long WP,Pray-Grant M,Tsai JC,Perdew GH. Protein kinase C activity is required for aryl hydrocarbon receptor pathway-mediated signal transduction. Mol Pharmacol 1998; 53: 691700.
  • 37
    Fayad R,Pini M,Sennello JA,Cabay RJ,Chan L,Xu A,Fantuzzi G. Adiponectin deficiency protects mice from chemically induced colonic inflammation. Gastroenterology 2007; 132: 60114.
  • 38
    Wang Y,Lam JB,Lam KS,Liu J,Lam MC,Hoo RL,Wu D,Cooper GJ,Xu A. Adiponectin modulates the glycogen synthase kinase-3β/β-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice. Cancer Res 2006; 66: 1146270.
  • 39
    Arditi JD,Venihaki M,Karalis KP,Chrousos GP. Antiproliferative effect of adiponectin on MCF7 breast cancer cells: a potential hormonal link between obesity and cancer. Horm Metab Res 2007; 39: 913.
  • 40
    Bai YP,Liu YH,Chen J,Song T,You Y,Tang ZY,Li YJ,Zhang GG. Rosiglitazone attenuates NF-κB-dependent ICAM-1 and TNF-α production caused by homocysteine via inhibiting ERK1/2/p38MAPK activation. Biochem Biophys Res Commun 2007; 360: 206.
  • 41
    Kundu JK,Shin YK,Surh YJ. Resveratrol modulates phorbol ester-induced pro-inflammatory signal transduction pathways in mouse skin in vivo: NF-κB and AP-1 as prime targets. Biochem Pharmacol 2006; 72: 150615.
  • 42
    Schmeck B,Zahlten J,Moog K,van Laak V,Huber S,Hocke AC,Opitz B,Hoffmann E,Kracht M,Zerrahn J,Hammerschmidt S,Rosseau S, et al. Streptococcus pneumoniae-induced p38 MAPK-dependent phosphorylation of RelA at the interleukin-8 promotor. J Biol Chem 2004; 279: 532417.
  • 43
    Bub JD,Miyazaki T,Iwamoto Y. Adiponectin as a growth inhibitor in prostate cancer cells. Biochem Biophys Res Commun 2006; 340: 115866.
  • 44
    Nishihara T,Matsuda M,Araki H,Oshima K,Kihara S,Funahashi T,Shimomura I. Effect of adiponectin on murine colitis induced by dextran sulfate sodium. Gastroenterology 2006; 131: 85361.
  • 45
    Wang MY,Orci L,Ravazzola M,Unger RH. Fat storage in adipocytes requires inactivation of leptin's paracrine activity: implications for treatment of human obesity. Proc Natl Acad Sci USA 2005; 102: 1801116.
  • 46
    Brakenhielm E,Veitonmaki N,Cao R,Kihara S,Matsuzawa Y,Zhivotovsky B,Funahashi T,Cao Y. Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci USA 2004; 101: 247681.
  • 47
    Kim KY,Kim JK,Han SH,Lim JS,Kim KI,Cho DH,Lee MS,Lee JH,Yoon DY,Yoon SR,Chung JW,Choi I, et al. Adiponectin is a negative regulator of NK cell cytotoxicity. J Immunol 2006; 176: 595864.
  • 48
    Jones SA,Richards PJ,Scheller J,Rose-John S. IL-6 transsignaling: the in vivo consequences. J Interferon Cytokine Res 2005; 25: 24153.
  • 49
    Rakoff-Nahoum S,Paglino J,Eslami-Varzaneh F,Edberg S,Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004; 118: 22941.
  • 50
    Munkholm P. Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther 2003; 18 ( Suppl 2): 15.
  • 51
    Chung YC,Chang YF. Serum interleukin-6 levels reflect the disease status of colorectal cancer. J Surg Oncol 2003; 83: 2226.
  • 52
    Galizia G,Lieto E,De Vita F,Romano C,Orditura M,Castellano P,Imperatore V,Infusino S,Catalano G,Pignatelli C. Circulating levels of interleukin-10 and interleukin-6 in gastric and colon cancer patients before and after surgery: relationship with radicality and outcome. J Interferon Cytokine Res 2002; 22: 47382.
  • 53
    Schneider MR,Hoeflich A,Fischer JR,Wolf E,Sordat B,Lahm H. Interleukin-6 stimulates clonogenic growth of primary and metastatic human colon carcinoma cells. Cancer Lett 2000; 151: 318.
  • 54
    Corvinus FM,Orth C,Moriggl R,Tsareva SA,Wagner S,Pfitzner EB,Baus D,Kaufmann R,Huber LA,Zatloukal K,Beug H,Ohlschlager P, et al. Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth. Neoplasia 2005; 7: 54555.
  • 55
    Jing N,Tweardy DJ. Targeting Stat3 in cancer therapy. Anticancer Drugs 2005; 16: 6017.
  • 56
    Jostock T,Mullberg J,Ozbek S,Atreya R,Blinn G,Voltz N,Fischer M,Neurath MF,Rose-John S. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. Eur J Biochem 2001; 268: 1607.
  • 57
    Kallen KJ. The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases. Biochim Biophys Acta 2002; 1592: 32343.
  • 58
    Atreya R,Neurath MF. Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer. Clin Rev Allergy Immunol 2005; 28: 18796.
  • 59
    Park PH,McMullen MR,Huang H,Thakur V,Nagy LE. Short-term treatment of RAW264.7 macrophages with adiponectin increases tumor necrosis factor-α (TNF-α) expression via ERK1/2 activation and Egr-1 expression: role of TNF-α in adiponectin-stimulated interleukin-10 production. J Biol Chem 2007; 282: 21695703.
  • 60
    Hattori Y,Hattori S,Kasai K. Globular adiponectin activates nuclear factor-κB in vascular endothelial cells, which in turn induces expression of proinflammatory and adhesion molecule genes. Diabetes Care 2006; 29: 13941.
  • 61
    Whitehead JP,Richards AA,Hickman IJ,Macdonald GA,Prins JB. Adiponectin—a key adipokine in the metabolic syndrome. Diabetes Obes Metab 2006; 8: 26480.
  • 62
    Schober F,Neumeier M,Weigert J,Wurm S,Wanninger J,Schaffler A,Dada A,Liebisch G,Schmitz G,Aslanidis C,Buechler C. Low molecular weight adiponectin negatively correlates with the waist circumference and monocytic IL-6 release. Biochem Biophys Res Commun 2007; 361: 96873.
  • 63
    Korner A,Pazaitou-Panayiotou K,Kelesidis T,Kelesidis I,Williams CJ,Kaprara A,Bullen J,Neuwirth A,Tseleni S,Mitsiades N,Kiess W,Mantzoros CS. Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies. J Clin Endocrinol Metab 2007; 92: 10418.
  • 64
    Dal Maso L,Augustin LS,Karalis A,Talamini R,Franceschi S,Trichopoulos D,Mantzoros CS,La Vecchia C. Circulating adiponectin and endometrial cancer risk. J Clin Endocrinol Metab 2004; 89: 11603.
  • 65
    Ishikawa M,Kitayama J,Kazama S,Hiramatsu T,Hatano K,Nagawa H. Plasma adiponectin and gastric cancer. Clin Cancer Res 2005; 11: 46672.
  • 66
    Fayad R,Pini M,Sennello JA,Cabay RJ,Chan L,Xu A,Fantuzzi G. Adiponectin deficiency protects mice from chemically induced colonic inflammation. Gastroenterology 2007; 132: 60114.